Mednow Inc
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies under the Mednow Pharmacy name located in the provinces of British Columbia and Ontario. The compa… Read more
Mednow Inc (MDNWF) - Net Assets
Latest net assets as of April 2023: $-5.83 Million USD
Based on the latest financial reports, Mednow Inc (MDNWF) has net assets worth $-5.83 Million USD as of April 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.28 Million) and total liabilities ($19.10 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.83 Million |
| % of Total Assets | -43.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 292.33 |
Mednow Inc - Net Assets Trend (2019–2022)
This chart illustrates how Mednow Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mednow Inc (2019–2022)
The table below shows the annual net assets of Mednow Inc from 2019 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-07-31 | $6.01 Million | -81.50% |
| 2021-07-31 | $32.49 Million | +503.16% |
| 2020-07-31 | $5.39 Million | +38773.83% |
| 2019-07-31 | $-13.93K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mednow Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3932147000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $31.66 Million | 520.43% |
| Other Comprehensive Income | $13.76 Million | 226.27% |
| Total Equity | $6.08 Million | 100.00% |
Mednow Inc Competitors by Market Cap
The table below lists competitors of Mednow Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Metair
JSE:MTA
|
$458.88K |
|
C WorldWide Emerging Markets KL
CO:CWIEMMKL
|
$459.03K |
|
Royal Canadian Mint Gold
TO:MNT
|
$459.06K |
|
LG Corp. Pfd. Series 1
KQ:003555
|
$459.34K |
|
ROSENBAUER INTERNAT - Dusseldorf Stock Exchang
DU:ROI
|
$458.39K |
|
BANK PEKAO (BP1.SG)
STU:BP1
|
$458.00K |
|
Sasfin
JSE:SFN
|
$457.92K |
|
Endexx Corp
PINK:EDXC
|
$457.48K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mednow Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 32,486,740 to 6,082,463, a change of -26,404,277 (-81.3%).
- Net loss of 29,482,917 reduced equity.
- Share repurchases of 119 reduced equity.
- Other comprehensive income increased equity by 5,204,232.
- Other factors decreased equity by 2,125,473.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-29.48 Million | -484.72% |
| Share Repurchases | $119.00 | -0.0% |
| Other Comprehensive Income | $5.20 Million | +85.56% |
| Other Changes | $-2.13 Million | -34.94% |
| Total Change | $- | -81.28% |
Book Value vs Market Value Analysis
This analysis compares Mednow Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.07x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-07-31 | $0.00 | $0.02 | x |
| 2020-07-31 | $0.25 | $0.02 | x |
| 2021-07-31 | $1.77 | $0.02 | x |
| 2022-07-31 | $0.28 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mednow Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -484.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -177.20%
- • Asset Turnover: 0.92x
- • Equity Multiplier: 2.98x
- Recent ROE (-484.72%) is below the historical average (-130.25%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-7.46K |
| 2020 | -8.72% | 0.00% | 0.00x | 1.03x | $-1.01 Million |
| 2021 | -27.56% | -2162.76% | 0.01x | 1.05x | $-12.20 Million |
| 2022 | -484.72% | -177.20% | 0.92x | 2.98x | $-30.09 Million |
Industry Comparison
This section compares Mednow Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mednow Inc (MDNWF) | $-5.83 Million | 0.00% | N/A | $458.45K |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |